Active immune mechanism in the female reproductive tract may produce high levels of anti-seminal/sperm antibodies. Generated antibodies in the process of isoimmunization seem to be associated with female immune infertility. The aim of our study consists in the profiling of specific serum immunoglobulin classes and subclasses in infertile women. We focus on the distribution of serum seminal/sperm-specific antibodies in order to find those apparently related to female isoimmunization. Immunoglobulins G 1-4 , A 1,2 , M and E were measured by ELISA in serum from 30 infertile and 10 fertile females. Anti-seminal/sperm IgG 1 and IgG 4 fractions were predominantly detected. Anti-seminal IgG 1 and IgG 4 were observed approximately in the 2:1 ratio, anti-sperm fraction in the 1:2 ratio. Strikingly, the approximate ratio between IgG 1 and IgG 2 was 3:1 in seminal specific and 2:1 in sperm specific antibodies. Surprisingly, IgG 3 antibodies were nearly negative for both antigen fractions, seminal and sperm. Concerning our results, the proportionality does exist between seminal and sperm antibody fractions. Based on the poorly detectable levels of semen specific IgE, M, A 1,2 , G 3 , the markers of pathologic female isoimmunization appear to be the serum IgG 1 and IgG 4 . These preliminary findings may contribute to a detailed patient diagnosis and an improved therapy.
Introduction
Human semen, that is defined as a complex fluid containing sperm, cellular vesicles and other cells and components (e.g., leucocytes, environmental antigens of microbial origin), could provoke the immune reaction of the female genital tract (Moldoveanu et al., 2005; Brazdova et al., 2013) . Semen immunoregulatory factors as well as immunogenic agents are, thus, the potential targets of activated inflammatory cytokines, initiate leukocyte infiltration and complement cascade in the female genital tract. The active local immunoregulatory mechanism of the female reproductive tract is related to the fertility potential (Wirth, 2007; Brazdova, 2014) . Sperm is able to induce the production of sperm-reactive T-cells in men as well as in women. Anti-sperm antibodies interfere with the antibody-mediated infertility through various pre/post-fertilization processes (Kurpisz and Kamieniczna, 2009; Brazdova et al., 2013) . Seminal antibody-binding proteins contribute to sperm metabolism, passage in the female reproductive tract and block an interaction with immune effectors. Seminal Fluid (SF) induces pro-inflammatory cytokines and suppresses the cell-mediated cytotoxicity (Chiu and Chamley, 2002; Brazdova et al., 2012a) . In primary response to some allergens/antigens, IgE antibodies might be prevalent. The so-called switch into IgG and IgA antibodies is induced at the late phase of primary immune response and/or after the repeated exposure to the same antigen (Batard et al., 1993) . After the chronic antigen exposure, IgG 1 and IgG 4 become the predominantly produced subclasses of IgG isotype. In addition, IgG 4 is unable to activate the classical complement pathway and is then known as an anti-inflammatory immunoglobulin and a blocking antibody towards IgE antibodies. Still, it remains unclear whether IgG 4 is a protective or rather sensitizing antibody (Aalberse and Schuurman, 2002; Guma and Firestein, 2012) .
In the present paper, the profile of antibody-based immune response to seminal/sperm proteins in infertile and fertile women is studied to document which class or subclass of serum immunoglobulin might be mostly involved in the immune rejection of sperm associated with female immune infertility.
Materials and Methods

Sample preparation
Semen samples from 8 normozoospermic (WHO, 2010) donors (aged 25-30) were treated as previously described (Brazdova et al., 2012a; Brazdova et al., 2013) . Sperm-free SF was processed untreated; the sperm disintegration was processed with Triton X-100. To increase the amount of potential antigens in the protein extracts and to eliminate individual variations, the obtained individual sperm Lysates (L) were pooled as well as individual SF. The samples were stored at -20 °C until assayed. All experiments were performed after obtaining informed written consent.
Patients
This study was approved by the institutional ethical committees and informed written consent was returned by patients. Sera were obtained from 30 women with a fertility disorder (patients with repeated in vitro fertilization failure, aged 29-38) and from 10 women (control group, aged 28-37) with proven fertility (1-2 healthy children). The serum samples were frozen at -20 °C until assayed.
Quantification of Serum Anti-Seminal/Sperm Immunoglobulins
Serum anti-seminal/sperm IgG 1-4 , IgA 1,2 , IgM, IgE and then the SF/L reactivity of patient and control sera were tested by ELISA developed in our laboratory.
In the first protocol, to obtain the standard calibration curves, the micro-plates (MaxiSorp TM , Denmark) were coated with either mouse anti-human IgG 1-4 (Calbiochem, United States), IgA 1,2 (Abcam, United Kingdom), goat anti-human IgM (Sigma-Aldrich, United States) or IgE (Sigma-Aldrich, United States) in a 50 mM carbonatebicarbonate buffer (Friguet et al., 1985) overnight at 4 °C. The plates were saturated with 0.5% gelatine (SigmaAldrich, United States) in PBS-Tw 0.1% (0.01 M Phosphate Buffered Saline with NaCl 0.15 M, pH 7.4 supplemented with Tween; Brazdova et al., 2012a,b) for 2 h at room temperature. The wells were incubated with the individual patient or control sera or human IgG 1-4 , IgA 1,2 , IgM, IgE (Calbiochem, United States) as standards of known concentration in serial dilution for 2 h at 37 °C in PBS-Tw 0.1% and then with alkaline phosphatase (AP)-conjugated, either mouse anti-human IgG 1-4 (Calbiochem, United States), IgA 1,2 (Beckman Coulter, United States), goat anti-human IgM or IgE (Sigma-Aldrich, United States) for 2 h at 37 °C. The AP activity was detected by p-nitrophenyl phosphate disodium (Sigma-Aldrich, United States). Optical density was measured at 405 nm versus 630 nm with a multichannel spectrophotometer (Tecan Group Ltd., Switzerland).
In the second protocol, to quantify the serum antiseminal/sperm IgG 1-4 , IgA 1,2 , IgM, IgE, the micro-plates were coated with SF/L in a 50 mM carbonate-bicarbonate buffer overnight at 4 °C. The following procedure was identical to the first protocol. The anti-seminal/sperm immunoglobulin concentrations were obtained by linear regression in comparison with the standard calibration curve obtained in the first protocol. Figure 1 shows the concentration of seminal/spermspecific IgG 1-4 in the individual sera of infertile/fertile females. In the sera of infertile women, the predominant anti-SF IgG subclasses were IgG 1 and IgG 4 , reaching maximum concentration of 45 µg/ml (IgG 1 ) and 38 µg/ml (IgG 4 ). In particular, anti-SF IgG 1 antibodies were detected in 100% of sera tested with the mean of 22 µg/ml (SD 9), IgG 2 in 97% with the mean of 8 µg/ml (SD 6), IgG 3 in 6% with the mean of 0.1 µg/ml (SD 0.05), IgG 4 in 90% with the mean of 12 µg/ml (SD 9). In the sera of infertile women, the prevalent anti-sperm IgG subclass was IgG 4 ranging from 9 to 45 µg/ml with the mean of 23 µg/ml (SD 10). Anti-sperm IgG 1-4 antibodies were detected within all patient sera processed with the mean of 11 (SD 5, IgG 1 ), 7.5 (SD 5, IgG 2 ), 0.3 (SD 0.1, IgG 3 ), 23 µg/ml (SD 10, IgG 4 ). Twenty percent of control sera contained seminal-specific IgG 1 and 30% contained seminal-specific IgG 2 , both of which ranged from 0.2 to 0.5 µg/ml. Sperm-specific IgG 1,2 were detected in 30% of control sera reaching the top value of 0.5 µg/ml. None of the control sera had the detectable levels of antiseminal/sperm IgG 3,4 . 
Results
Discussion
We present our essential preliminary findings concerning the distribution of serum anti-SF/L IgG 1,2,3,4 , IgA 1,2 , IgM and IgE as a consequence of pathophysiological female isoimmunization. We show IgG 1 /IgG 4 predominance depending on the values themselves, 2:1 in anti-seminal specific antibodies, also valid in a reverse statement between anti-sperm IgG 1 and IgG 4 levels. The IgG 1 :IgG 4 ratio in anti-sperm antibodies is in agreement with the working hypothesis of Batard et al. (1993) who proved that the prolonged exposure to immunogenic agents, such as grass pollen allergens, generates IgG 1 further shifting into IgG 4 . Then, we speculate that the detected antigens might be the same since the distribution of tested antibodies follows the similar trend of IgG 1 >IgG 2 >IgG 3 <<IgG 4 . Based on barely detectable IgG 3 within the patient group, we assume that IgG 3 does not have any protective or inflammatory role in female immune infertility. Among the four IgG subclasses, IgG 1,3 activate complement cascade (Jefferis, 2012) . Since patients do not suffer from the inflammatory symptoms, we suggest that complement cascade may not be activated by IgG 3 in the semen rejection. It was specified (Tamayo et al., 2012) that the response to protein antigens is primarily mediated by IgG 1 and IgG 3 , whereas IgG 2 especially and IgG 4 are induced in response to polysaccharide antigens. Since seminal/sperm-specific IgG 1 and IgG 4 were inversely correlated, IgG 1 could theoretically bind to seminal antigens of a protein character and IgG 4 to sperm structures of an oligosaccharide nature. Whether or not serum IgG 4 is a blocking or sensitizing antibody in infertile females remains unexplained, unlike in other studies dealing with other pathologies (Aalberse and Schuurman, 2002; Guma and Firestein, 2012) . The absence of data following patients over time prevented us to better understand the role of IgG 4 . Concerning male autoimmunity, IgA antibodies were proved to be associated with a systematic factor in male immune infertility (Kutteh et al., 1994) . The nondetectable levels of IgA 1,2 in 97% of female patient sera tested imply that either IgA 1 or IgA 2 do not correlate with systemic isoimmunization. However, we are able to affirm that only IgA 1 is not involved in the disease as it predominates in the sera (Woof and Kerr, 2006 ) examined in our study. Immunoglobulin M contributes to opsonization and is involved in the primary response to antigen exposure (Schoeder and Cavacini, 2010) . Since the patient sera are neither collected nor tested immediately after the sensitization, the nondetectable level reflects the potential secondary immune response where IgM does not play a significant role. However, we cannot refute that IgM is not involved either in primary or secondary antibody response to isoimmunization. Not a single patient was diagnosed with semen hypersensitivity, which is in agreement with an absence of anti-seminal/sperm IgE, usually related to the pathophysiology of allergy (Brazdova et al., 2012a,b) .
Conclusion
The described distribution of seminal/sperm-specific IgG 1,2,3,4 , IgA 1,2 , IgM, IgE indicates that female isoimmunization seems to be IgG-dependent as immunoglobulins E, M, A 1,2 are not involved in this pathophysiological process. Specific IgG 1 predominates in anti-seminal serum antibody fraction; on a contrary, specific IgG 4 in anti-sperm serum antibody fraction. We believe that the determination of serum seminal/spermspecific immunoglobulin G subclasses might make patient profiling more precise and complete the information for diagnosis. Anti-seminal/sperm IgG 1 and IgG 4 could be of interest for further therapy targets.
